CARUBBI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.769
EU - Europa 1.026
AS - Asia 704
OC - Oceania 5
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 3.510
Nazione #
US - Stati Uniti d'America 1.763
IE - Irlanda 345
CN - Cina 241
SE - Svezia 202
SG - Singapore 201
TR - Turchia 119
IT - Italia 108
HK - Hong Kong 107
DE - Germania 106
UA - Ucraina 80
GB - Regno Unito 60
FI - Finlandia 38
FR - Francia 35
BE - Belgio 28
IN - India 14
VN - Vietnam 13
CZ - Repubblica Ceca 8
NL - Olanda 5
RU - Federazione Russa 5
CA - Canada 4
NZ - Nuova Zelanda 3
AU - Australia 2
BR - Brasile 2
EU - Europa 2
ID - Indonesia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ES - Italia 1
IR - Iran 1
JO - Giordania 1
JP - Giappone 1
LB - Libano 1
LU - Lussemburgo 1
MX - Messico 1
PH - Filippine 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 3.510
Città #
Chandler 396
Dublin 338
Jacksonville 312
Singapore 167
Boardman 116
Santa Clara 116
Ann Arbor 106
Hong Kong 106
Izmir 89
New York 66
Nanjing 54
Wilmington 48
Lawrence 47
Princeton 47
Ashburn 38
Woodbridge 38
Dearborn 36
Beijing 35
L'aquila 33
Brussels 28
San Mateo 23
Nanchang 18
Los Angeles 17
Milan 17
Helsinki 16
Dong Ket 12
Pescara 12
Seattle 12
Verona 12
Dallas 11
L’Aquila 11
Des Moines 10
Grafing 10
Jiaxing 10
Hebei 9
Kunming 9
Shanghai 9
Shenyang 9
Tianjin 9
Bremen 8
Jinan 8
Mountain View 8
Munich 8
Ningbo 7
Hangzhou 6
Brno 5
Changsha 5
Berlin 4
Hefei 4
Pune 4
Aquila 3
Auckland 3
Edinburgh 3
Falls Church 3
Guangzhou 3
Kitzingen 3
Naples 3
Olomouc 3
Taizhou 3
Zhengzhou 3
Cedar Knolls 2
Changchun 2
Houston 2
Intra 2
Jinhua 2
Lanzhou 2
Norwalk 2
Novara 2
Orange 2
Phoenix 2
Tappahannock 2
Washington 2
Amman 1
Auburn Hills 1
Baku 1
Bandung 1
Basel 1
Bournemouth 1
Bratislava 1
Brisbane 1
Central District 1
Centurion 1
Chongqing 1
Città di Castello 1
Fairfield 1
Frankfurt am Main 1
Fremont 1
Halfweg 1
Harbin 1
Huaibei 1
Isernia 1
Kish 1
Kocaeli 1
Langfang 1
Lappeenranta 1
Luxembourg 1
Madrid 1
Manila 1
Melbourne 1
Montreal 1
Totale 2.601
Nome #
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 120
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 107
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 103
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 100
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 100
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 99
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 96
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 96
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 95
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 87
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 86
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 85
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 85
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 83
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 82
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 80
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 80
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 79
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 77
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 77
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 75
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 73
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 72
Interstitial lung disease in systemic sclerosis: current and future treatment. 72
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 71
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 68
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 68
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients with Sjögren's Syndrome: Comment on the Article by Nocturne et al 67
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 67
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 64
Diet in rheumatoid arthritis versus systemic lupus erythematosus: Any differences? 64
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 63
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 62
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 61
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 61
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 60
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 59
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 57
Pericarditis after sars‐cov‐2 infection: Another pebble in the mosaic of long covid? 57
Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis 56
Blood Pressure Profiles and Cognitive Function from Adulthood to Old Age: Chasing a Golden Middle Way? 56
Adherence to the Mediterranean diet and the impact on clinical features in primary Sjögren's syndrome 51
Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis 50
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units 47
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 46
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 46
Potential of stem cells in the treatment of rheumatic disease 36
The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren’s Syndrome: Is Uric Acid the Missing Link? 27
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares 26
The URRAH study 25
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 20
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 18
Electrocardiographic Abnormalities in Hospitalized Patients with COVID-19 and the Associations with Clinical Outcome 18
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 15
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 14
Different clinical presentations of primary Sjögren's syndrome: Not only a matter of age. Comment on: “Elderly-onset primary Sjögren's syndrome focused on clinical and salivary gland ultrasonographic features by Lee et al. Joint Bone Spine. 2021;88:105132” 14
SpA plus IBD or IBD plus SpA: Does commutative property apply? 13
Totale 3.636
Categoria #
all - tutte 17.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020223 0 0 0 0 0 0 70 19 43 17 3 71
2020/2021419 15 43 0 55 49 22 56 4 47 28 66 34
2021/2022397 24 10 97 41 9 18 7 18 20 36 25 92
2022/20231.040 82 84 18 138 81 104 1 52 428 9 26 17
2023/2024272 41 13 14 18 22 89 4 12 2 15 9 33
2024/2025578 40 32 110 61 133 94 108 0 0 0 0 0
Totale 3.636